Sangamo Therapeutics, Inc.SGMONASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank53
3Y CAGR-16.1%
5Y CAGR-11.2%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
-16.1%/yr
vs +7.6%/yr prior
5Y CAGR
-11.2%/yr
Recent deceleration
Acceleration
-23.7pp
Decelerating
Percentile
P53
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
5 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $36.99M | -17.3% |
| 2024 | $44.73M | -26.9% |
| 2023 | $61.17M | -2.4% |
| 2022 | $62.68M | -0.8% |
| 2021 | $63.22M | -5.8% |
| 2020 | $67.10M | +8.8% |
| 2019 | $61.69M | +32.0% |
| 2018 | $46.74M | +71.8% |
| 2017 | $27.20M | +3.3% |
| 2016 | $26.33M | - |